Rhapsody builds interoperability infrastructure for healthcare data, with a particular emphasis on preparing that data for use in agentic AI systems. Founded in 2018, the company provides the plumbing that allows care providers, health-tech builders, payers, and public health teams to integrate data across complex and fragmented environments. Its work sits at the intersection of health data exchange, data integration, and data quality management - domains in which usable, well-structured data is the precondition for any downstream machine-learning or agent-based application.
The company's product line includes the Rhapsody interoperability platform, which connects systems to reduce integration burden; agent-ready interoperability infrastructure, designed to make healthcare data accessible to agentic AI; and data quality solutions intended to reduce risk, rework, and stalled initiatives across providers, payers, and digital health innovators. The platform is trusted by more than 1,900 healthcare organisations, with customers in more than 33 countries.
Rhapsody is privately held, having been acquired by the private equity firm Hg Capital. Its stated mission is oriented towards making healthcare safer, more efficient, and more equitable, with an emphasis on better health outcomes, lower costs, and thriving communities. Technical work spans healthcare data interoperability, data quality management, health data exchange, and the infrastructure required to make clinical data fit for agentic AI.
